Page last updated: 2024-11-06

2,4,6-trihydroxyacetophenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,4,6-Trihydroxyacetophenone (THA) is a natural phenolic compound found in various plants, including berries, grapes, and medicinal herbs. It exhibits a wide range of biological activities, including antioxidant, anti-inflammatory, and antimicrobial properties.

THA is often synthesized through various methods, including the acetylation of phloroglucinol or the Friedel-Crafts acylation of resorcinol.

Its antioxidant properties are attributed to its ability to scavenge free radicals, which contribute to oxidative stress and cellular damage. THA has shown promise in protecting against oxidative damage in various models, including liver and brain cells.

Furthermore, THA has demonstrated anti-inflammatory effects by inhibiting the production of inflammatory mediators like prostaglandins and leukotrienes.

Its antimicrobial activity is attributed to its ability to disrupt bacterial cell membranes and interfere with essential metabolic processes.

Due to its multifaceted biological activities, THA has been studied extensively for its potential therapeutic applications in various conditions, including cancer, diabetes, and neurodegenerative diseases.

Research on THA continues to explore its mechanisms of action, potential applications, and safety profile.'

monoacetylphloroglucinol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2',4',6'-trihydroxyacetophenone : A benzenetriol that is acetophenone in which the hydrogens at positions 2, 4, and 6 on the phenyl group are replaced by hydroxy groups. It is used as a matrix in matrix-assisted laser desorption/ionization (MALDI) mass spectrometry for the analysis of acidic glycans and glycopeptides. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Lasergenus[no description available]ApiaceaeA large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.[MeSH]

Cross-References

ID SourceID
PubMed CID68073
CHEMBL ID452477
CHEBI ID64344
SCHEMBL ID105416
MeSH IDM0278698

Synonyms (82)

Synonym
AC-12835
2',4',6'-trihydroxyacetophenone
nsc 54927
einecs 207-556-5
1-(2,4,6-trihydroxy-phenyl)-ethanone
acetophenone, 2',4',6'-trihydroxy-
SDCCGMLS-0066935.P001
2,4,6-trihydroxyacetophenone monohydrate
phloroacetophenone
acetylphloroglucinol
ethanone,4,6-trihydroxyphenyl)-
nsc-54927
2',6'-trihydroxyacetophenone
480-66-0
1-(2,6-trihydroxyphenyl)ethanone
acetophenone,4',6'-trihydroxy-
acetophloroglucine
nsc54927
ACON1_001026
ethanone, 1-(2,4,6-trihydroxyphenyl)-
inchi=1/c8h8o4/c1-4(9)8-6(11)2-5(10)3-7(8)12/h2-3,10-12h,1h
1-(2,4,6-trihydroxyphenyl)ethanone
NCGC00095604-01
SPBIO_002177
SPECTRUM2_001989
SPECTRUM300604
NCGC00095604-02
2, 4, 6-trihydroxyacetophenone
bdbm50249070
BRD-K64824948-001-02-2
2,4,6-trihydroxyacetophenone
CHEMBL452477 ,
2,4,6-trihydroxy acetophenone
chebi:64344 ,
2-acetylphloroglucinol
T1888
phloracetophenone
2,4,6-trihydroxy-acetophenone
4-mono-hydroxy-acetophenone
2,4,-dihydroxy-acetophenone
1-(2,4,6-trihydroxyphenyl)-ethanone
unii-8l7xd8830t
8l7xd8830t ,
5-alpha-thenil
thap
1-(2,4,6-trihydroxyphenyl)ethan-1-one
CCG-39527
AKOS005175228
phloroacetophenone monohydrate
2-acetylphloroglucinol monohydrate
FT-0688182
monoacetylphloroglucinol
FT-0601335
PS-5270
S4784
SCHEMBL105416
1-(2,4,6-trihydroxyphenyl]ethanone
DTXSID5060061
phloracetophene
W-106057
HY-W008226
CS-W008226
SR-05000002401-1
sr-05000002401
2`,4`,6`-trihydroxyacetophenone monohydrate
83x ,
1-[2,4,6-tris(oxidanyl)phenyl]ethanone
2-acetyl-1,3,5-benzenetriol
acetophenone, 2',4',6'-trihydroxy- (8ci)
1-(2,4, 6-trihydroxyphenyl)ethanone
2',4',6'-trihydroxy-acetophenone
acetophloroglucinol
1-(2,4,6-trihydroxyphenyl)ethanone, 9ci
Q4596772
SY031234
mfcd00002287
2 inverted exclamation mark ,4 inverted exclamation mark ,6 inverted exclamation mark -trihydroxyacetophenone
C21895
BRD-K64824948-001-03-0
STL194090
CK2566
EN300-51759

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" These results suggested that THA at biologically active choleretic dose had low toxicity, it might be safe for further development as a therapeutic agent for a short period of treatment in cholestasis."( Evaluation of the acute and subacute toxicity of a choleretic phloracetophenone in experimental animals.
Chuncharunee, A; Komaratat, P; Piyachaturawat, P; Suksamrarn, A; Tubtim, C, 2002
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
MALDI matrix materialA compound used to form the matrix for MALDI (matrix-assisted laser desorption/ionization) mass spectrometry. MALDI matrix materials are crystalline compounds with a fairly low molecular weight, so as to allow facile vaporization, have strong absorption at UV or IR wavelengths (to rapidly and efficiently absorb laser irradiation), generally contain polar groups (enabling them to be used in aqueous solutions) and are frequently acidic (so assisting ionisation of the compound being studied, which is contained within the matrix material).
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
methyl ketoneA ketone of formula RC(=O)CH3 (R =/= H).
benzenetriolA triol in which three hydroxy groups are substituted onto a benzene ring.
aromatic ketoneA ketone in which the carbonyl group is attached to an aromatic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (21)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
USP1 protein, partialHomo sapiens (human)Potency28.18380.031637.5844354.8130AID504865
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency12.58930.001815.663839.8107AID894
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency3.16230.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Neuronal proto-oncogene tyrosine-protein kinase Src Mus musculus (house mouse)IC50 (µMol)194.70000.00901.10452.2000AID1321832
Solute carrier family 28 member 3Homo sapiens (human)Ki100.00002.10002.75003.4000AID370698
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (10)

Processvia Protein(s)Taxonomy
xenobiotic metabolic processSolute carrier family 28 member 3Homo sapiens (human)
xenobiotic transmembrane transportSolute carrier family 28 member 3Homo sapiens (human)
pyrimidine nucleobase transportSolute carrier family 28 member 3Homo sapiens (human)
uridine transmembrane transportSolute carrier family 28 member 3Homo sapiens (human)
sodium ion transmembrane transportSolute carrier family 28 member 3Homo sapiens (human)
pyrimidine-containing compound transmembrane transportSolute carrier family 28 member 3Homo sapiens (human)
nucleoside transmembrane transportSolute carrier family 28 member 3Homo sapiens (human)
purine nucleobase transmembrane transportSolute carrier family 28 member 3Homo sapiens (human)
pyrimidine nucleoside transportSolute carrier family 28 member 3Homo sapiens (human)
purine nucleoside transmembrane transportSolute carrier family 28 member 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
protein tyrosine kinase activityNeuronal proto-oncogene tyrosine-protein kinase Src Mus musculus (house mouse)
purine nucleobase transmembrane transporter activitySolute carrier family 28 member 3Homo sapiens (human)
nucleoside:sodium symporter activitySolute carrier family 28 member 3Homo sapiens (human)
protein bindingSolute carrier family 28 member 3Homo sapiens (human)
uridine transmembrane transporter activitySolute carrier family 28 member 3Homo sapiens (human)
purine-specific nucleoside:sodium symporter activitySolute carrier family 28 member 3Homo sapiens (human)
pyrimidine- and adenosine-specific:sodium symporter activitySolute carrier family 28 member 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
nucleoplasmNeuronal proto-oncogene tyrosine-protein kinase Src Mus musculus (house mouse)
cytosolNeuronal proto-oncogene tyrosine-protein kinase Src Mus musculus (house mouse)
plasma membraneNeuronal proto-oncogene tyrosine-protein kinase Src Mus musculus (house mouse)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
endoplasmic reticulum membraneSolute carrier family 28 member 3Homo sapiens (human)
plasma membraneSolute carrier family 28 member 3Homo sapiens (human)
brush border membraneSolute carrier family 28 member 3Homo sapiens (human)
plasma membraneSolute carrier family 28 member 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (31)

Assay IDTitleYearJournalArticle
AID1537671Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery.
AID607598Cytotoxicity against human LoVo cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID510840Cytotoxicity against human HL60 cells after 72 hrs by XTT assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Prenylflavonoids and prenyl/alkyl-phloroacetophenones: synthesis and antitumour biological evaluation.
AID1537669Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery.
AID395643Activity of Crotalus adamanteus venom PLA2 assessed as 1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphoglycerol hydrolysis at 0.30 uM2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Molecular modeling and inhibition of phospholipase A2 by polyhydroxy phenolic compounds.
AID1537670Cytotoxicity against human U937 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery.
AID607595Cytotoxicity against human A549 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID1537673Cytotoxicity against human REH cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery.
AID510839Cytotoxicity against human HT-29 cells after 72 hrs by XTT assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Prenylflavonoids and prenyl/alkyl-phloroacetophenones: synthesis and antitumour biological evaluation.
AID607601Cytotoxicity against human U373 cells assessed as growth inhibition at MTT assay-related IC50 by quantitative video microscopy relative to control2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID395644Inhibition of Crotalus adamanteus venom PLA2 assessed as effect on 1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphoglycerol hydrolysis at 0.15 uM2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Molecular modeling and inhibition of phospholipase A2 by polyhydroxy phenolic compounds.
AID1537674Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery.
AID1433210Antiplasmodial activity against intraerythrocytic stage of Plasmodium falciparum Dd2 assessed as parasite growth inhibition after 72 hrs by SYBR Green I dye-based assay2016Journal of natural products, 06-24, Volume: 79, Issue:6
Synthesis and Antimalarial Activity of Mallatojaponin C and Related Compounds.
AID510838Cytotoxicity against human A549 cells after 72 hrs by XTT assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Prenylflavonoids and prenyl/alkyl-phloroacetophenones: synthesis and antitumour biological evaluation.
AID1321832Inhibition of Src in mouse BV2 cells assessed as suppression of LPS-induced NO release preincubated for 1 hr followed by LPS addition measured after 24 hrs by Griess assay2016Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
A Novel Parkinson's Disease Drug Candidate with Potent Anti-neuroinflammatory Effects through the Src Signaling Pathway.
AID607597Cytotoxicity against human SK-MEL-28 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID395646Inhibition of Crotalus adamanteus venom PLA2-induced edema in Swiss mouse at 50 ug, id2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Molecular modeling and inhibition of phospholipase A2 by polyhydroxy phenolic compounds.
AID370698Binding affinity to human recombinant CNT3 expressed in pig PK15NTD cells assessed as [3H]uridine uptake by beta-scintillation counter2009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors.
AID381257Cytotoxicity against human 9KB cells assessed as cell survival at 10 ug/ml relative to control
AID607600Induction of human U373 cell death assessed as morphological changes at MTT assay-related IC50 after 72 hrs by quantitative video microscopy2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID381256Cytotoxicity against human 9KB cells assessed as cell survival at 100 ug/ml relative to control
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID607593Cytotoxicity against human U373 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID1537672Cytotoxicity against human MIAPaCa2 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery.
AID395645Inhibition of Crotalus adamanteus venom PLA2 assessed as effect on 1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphoglycerol hydrolysis at 0.30 uM2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Molecular modeling and inhibition of phospholipase A2 by polyhydroxy phenolic compounds.
AID607596Cytotoxicity against human PC3 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID395642Activity of Crotalus adamanteus venom PLA2 assessed as 1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphoglycerol hydrolysis at 0.15 uM2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Molecular modeling and inhibition of phospholipase A2 by polyhydroxy phenolic compounds.
AID607594Cytotoxicity against human OE21 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID510837Cytotoxicity against human HeLa cells after 72 hrs by XTT assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Prenylflavonoids and prenyl/alkyl-phloroacetophenones: synthesis and antitumour biological evaluation.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (60)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (3.33)18.2507
2000's23 (38.33)29.6817
2010's33 (55.00)24.3611
2020's2 (3.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.07

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.07 (24.57)
Research Supply Index4.14 (2.92)
Research Growth Index5.35 (4.65)
Search Engine Demand Index29.80 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.07)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.61%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other61 (98.39%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]